{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:55:07Z","timestamp":1792616107816,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00550","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:40:38Z","timestamp":1537404038000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":404,"title":["Vitamin D Toxicity\u2013A Clinical Perspective"],"prefix":"10.3389","volume":"9","author":[{"given":"Ewa","family":"Marcinowska-Suchowierska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kupisz-Urba\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"\u0141ukaszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"P\u0142udowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenville","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"B1","unstructured":"BouillonR\n          Vitamin D and Extraskeletal Health. UpToDate2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mayocp.2015.02.012","article-title":"Changing incidence of serum 25-hydroxyvitamin D values above 50 ng\/ml: a 10-year population-based study","volume":"90","author":"Dudenkov","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D\u2013mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.mayocp.2015.03.015","article-title":"Vitamin D is not as toxic as was once thought: a historical and up-to-date perspective","volume":"90","author":"Holick","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"B5","first-page":"236","article-title":"Hypervitaminosis D and systemic manifestations: a comprehensive review","volume":"27","author":"Gupta","year":"2014","journal-title":"JIMSA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1172\/JCI109442","article-title":"Evidence that increased circulating 1\u03b1, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis","volume":"64","author":"Bell","year":"1979","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(19870501)59:9<1543::AID-CNCR2820590902>3.0.CO;2-L","article-title":"Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia","volume":"59","author":"Mudde","year":"1987","journal-title":"Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"3655","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00467-014-2889-1","article-title":"Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake","volume":"30","author":"Dinour","year":"2015","journal-title":"Pediatr Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13353-017-0397-2","article-title":"Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases","volume":"58","author":"Pronicka","year":"2017","journal-title":"J Appl Genet"},{"key":"B12","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/jama.1938.02790440026006","article-title":"The treatment of rheumatoid arthritis with large doses of vitamin D","volume":"111","author":"Abrams","year":"1938","journal-title":"JAMA"},{"key":"B13","first-page":"1659","article-title":"Vitamin D toxicity a British paediatric association report. Infantile hypercalcemia, nutritional rickets, and infantile scurvy in Great Britain","volume":"1","author":"Samuel","year":"1984","journal-title":"Br Med J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199204303261801","article-title":"Hypervitaminosis D associated with drinking milk","volume":"326","author":"Jacobus","year":"1992","journal-title":"N Engl J Med"},{"key":"B15","first-page":"1","volume-title":"(Institute of Medicine) Dietary Reference Intakes for Calcium and Vitamin D","year":"2011"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1001\/archinternmed.2009.361","article-title":"Vitamin D treatment for vitamin D deficiency and insufficiency for up to 6 years","volume":"169","author":"Pietras","year":"2009","journal-title":"Arch Inter Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e111265","DOI":"10.1371\/journal.pone.0111265","article-title":"The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers","volume":"9","author":"Ekwaru","year":"2014","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ajcn\/88.2.582S","article-title":"Pharmacokinetics of vitamin D toxicity","volume":"88","author":"Jones","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"B19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1995.tb02916.x","article-title":"Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate","volume":"43","author":"Selby","year":"1995","journal-title":"Clin Endocrinol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1210\/jcem-63-4-954","article-title":"Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D\u2013binding protein","volume":"63","author":"Bikle","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/endo-124-2-649","article-title":"Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes","volume":"124","author":"Bikle","year":"1989","journal-title":"Endocrinology"},{"key":"B22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-122-7-199504010-00006","article-title":"Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity","volume":"122","author":"Pettifor","year":"1995","journal-title":"Ann Intern Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.abb.2010.10.012","article-title":"1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or25-hydroxyvitamin D","volume":"505","author":"Deluca","year":"2011","journal-title":"Arch BiochemBiophys"},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000486073","article-title":"Hypercalcemic states associated with abnormalities of vitamin D metabolism","volume":"50","author":"Jones","year":"2018","journal-title":"Front Horm Res."},{"key":"B25","first-page":"3096","article-title":"Disorders of the parathyroid gland and calcium homeostasis","volume-title":"Harrison's Principles of Internal Medicine.","author":"Potts","year":"2012"},{"key":"B26","first-page":"44","article-title":"Vitamin D toxicity: a case study","volume":"64","author":"Khieng","year":"2010","journal-title":"N Zeal J Med Lab Sci"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-381978-9.10072-1","article-title":"Hypercalcemia due to vitamin D toxicity","volume-title":"Vitamin D","author":"Cusano","year":"2011"},{"key":"B28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/bmj.295.6607.1173","article-title":"Hepatic microsomal enzyme induction: treatment of vitamin D poisoning in a 7 month old baby","volume":"295","author":"\u0141ukaszkiewicz","year":"1987","journal-title":"Br Med J."},{"key":"B29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jcem-66-5-934","article-title":"Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients","volume":"66","author":"Glass","year":"1988","journal-title":"J ClinEndocrinol Metab"},{"key":"B30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/0003-4819-111-5-437","article-title":"Effective reduction in the serum 1,25 dihydroxyvitamin D and calcium concentration in sarcoidosis associated hypercalcemia with short course chloroquine therapy","volume":"11","author":"Adams","year":"1989","journal-title":"Ann Intern Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jc.2016-4048","article-title":"CYP3A4 induction by rifampin: an alternative pathway for vitamin d inactivation in patients with CYP24A1 mutations","volume":"102","author":"Hawkes","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/aje\/kww244","article-title":"The reverse j-shaped association between serum total 25-Hydroxyvitamin D concentration and all-cause mortality: the impact of assay standardization","volume":"185","author":"Durazo-Arvizu","year":"2017","journal-title":"Am J Epidemiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","article-title":"Monthly high-dose vitamin d treatment for the prevention of functional decline: a randomized clinical trial","volume":"176","author":"Bischoff-Ferrari","year":"2016","journal-title":"JAMA Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E953","DOI":"10.3390\/nu10080953","article-title":"Development of vitamin D toxicity from overcorrection of vitamin D deficiency: a review of case report","volume":"10","author":"Galior","year":"2018","journal-title":"Nutrients"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00550\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:40:54Z","timestamp":1537404054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00550\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":37,"alternative-id":["10.3389\/fendo.2018.00550"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00550","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"article-number":"550"}}